Compared with healthy controls, circulating microbiota-reactive CD4+ T cells from IBD patients displayed increased IL17A and IL2 production, but decreased expression of IFN-gamma (Figure 7A and Supplementary Figure 6D and E). The gene discussed is IL17A; the disease is inflammatory bowel disease.